Western Alliance Q2 FY26 net income climbs 13.03% to $268.8 million; revenue rises 17.71% to $995.7 million
Reuters2026/07/31 20:22- Western Alliance posted Q2 net income available to common stockholders of $258.5 million, up 13.78% year over year; diluted EPS rose 14.01% to $2.36.
- Net revenue climbed 17.71% to $995.7 million, while net interest margin was unchanged at 3.53%.
- Provision for credit losses jumped to $80.4 million from $39.9 million a year earlier; annualized net loan charge-offs rose to 0.37% from 0.22%.
- Nonperforming loans to funded held-for-investment loans increased to 0.92% from 0.85% at Dec. 31, 2025; total deposits rose 6.1% to $81.9 billion.
- Management launched a deposit optimization strategy in Q2 to reduce higher-cost balances, cutting more than $1 billion of higher-cost deposits near quarter-end.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Most panda coin types from the 2026 edition steadily rebounded in August
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations